ArticleHospital pharmacy2024

Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series.

Sami Barakat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.